Credit Suisse First Boston has won an advantage over rivals such as Deutsche Bank, HSBC and JP Morgan by winning regulatory approval to operate in China's fledgling derivatives market.
The go-ahead could give CSFB the first pure investment bank to win a derivatives licence in China a head start over competitors by enabling it to sell interest rates, credit and foreign exchanges derivatives directly to Chinese companies.
